Your health can’t wait. Learn how we’re making our facilities safer and schedule your care now.
Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #9 Nationally by U.S. News & World Report.
Through this multi-center Children’s Oncology Group study, researchers are investigating the potential of larotrectinib for treatment of certain cancers in infants, children and young adults. Specifically researchers will evaluate larotrectinib used in treatment of solid tumors with a mutation called a TRK fusion or leukemia that has come back or been resistant to standard therapy. Larotrectinib is a type of drug that works by blocking cell signal proteins that are thought to be important for tumors to grow.
Subject to certain exclusion criteria, this study is enrolling pediatric patients who have a newly diagnosed tumor that has not been previously treated or leukemia that is refractory or recurrent.
Males and Females: Up to 30 years of age
Participants will take larotrectinib twice daily as a capsule or liquid in 28-day cycles and may continue to receive it for up to 2 years, barring serious side effects or worsening of the cancer. If necessary, leukemia patients may receive additional drugs through spinal infusion at certain intervals. Throughout the treatment period, participants’ cancer will be evaluated at intervals defined in the protocol. Participants will need maintain and submit monthly medication journals for the research team. Participants will be followed for up to 3 years following end of treatment.
Visits: Approximately monthly through the 2-year dosing period, however the actual number of visits will vary by cohort and individual patient condition.
Duration: Up to 2 years for treatment with participants followed for another 3 years
Children’s Oncology Group (ADVL1823)
Study Description at the National Institutes of Health
Cancer and Blood Disorder Research
Children’s Oncology Group CureSearch
Leukemia Overview and Causes
Andrew Bukowinski, MD
For more information about the study or enrollment, please contact:
Sharon Dibridge, Clinical Research Coordinator
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.